Skip to content

Application of New Sanhuang Ointment External Application Therapy in Patients Undergoing General Anesthesia for Pulmonary Surgery After Double Lumen Tracheal Intubation and extubation

Application of New Sanhuang Ointment External Application Therapy in Patients Undergoing General Anesthesia for Pulmonary Surgery After Double Lumen Tracheal Intubation and extubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002015
Enrollment
Unknown
Registered
2025-10-22
Start date
2024-11-18
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Lung Tumor

Interventions

Group A (Intervention Group): Xin Sanhuang Ointment:Xin Sanhuang Ointment Topical Application Therapy
Group B (Control Group: Yellow Petroleum Jelly):Following anesthetic induction, the skin was cleansed. To ensure baseline consistency, Yellow Petroleum Jelly, which served as the solvent for the Xin S

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: ASA Physical Status Class I, II, III:Class I (A normal healthy patient): e.g., healthy, non-smoking, no or minimal alcohol consumption.Class II (A patient with mild systemic disease): Mild systemic disease without substantive functional limitations. Examples include: smoking, alcohol consumption, pregnancy, obesity (30 3 months ago). Age: 20-70 years old; BMI: 18.0-28.0 kg/m²; Patients scheduled for elective pulmonary surgery under general anesthesia with double-lumen endotracheal intubation; Anticipated intubation time >2 h

Exclusion criteria

Exclusion criteria: Preoperative pharyngeal discomfort; Suspected difficult airway; More than two attempts at tracheal intubation; History of respiratory diseases such as asthma; Intraoperative requirement for nasogastric tube insertion; Emergency patients or those transferred to the ICU postoperatively with an endotracheal tube; Inability to cooperate with postoperative follow-up; History of severe cardiac, pulmonary, hepatic, or renal diseases, or diabetes mellitus; Pre-existing tracheostomy, limited cervical mobility, or neck trauma.

Design outcomes

Primary

MeasureTime frame
Postoperative Sore Throat Pain Score;Visual Analog Scale (VAS) Score for Throat Pain;

Secondary

MeasureTime frame
Endotracheal Tube Tolerance;Hoarseness;Comfort Score;Satisfaction ;

Countries

China

Contacts

Public ContactShaobo Pan

Associate Chief Nursing Specialist, The First Affiliated Hospital, Zhejiang University School of Medicine

pan8127796@163.com13819100635

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026